rs397515393
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017950.4(CCDC40):c.248del(p.Ala83ValfsTer84) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000563 in 1,600,206 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00059 ( 0 hom. )
Consequence
CCDC40
NM_017950.4 frameshift
NM_017950.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -4.80
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-80039965-GC-G is Pathogenic according to our data. Variant chr17-80039965-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 31069.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80039965-GC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC40 | NM_017950.4 | c.248del | p.Ala83ValfsTer84 | frameshift_variant | 3/20 | ENST00000397545.9 | NP_060420.2 | |
CCDC40 | NM_001243342.2 | c.248del | p.Ala83ValfsTer84 | frameshift_variant | 3/18 | NP_001230271.1 | ||
CCDC40 | NM_001330508.2 | c.248del | p.Ala83ValfsTer84 | frameshift_variant | 3/11 | NP_001317437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC40 | ENST00000397545.9 | c.248del | p.Ala83ValfsTer84 | frameshift_variant | 3/20 | 5 | NM_017950.4 | ENSP00000380679 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 152026Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
41
AN:
152026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000441 AC: 109AN: 247240Hom.: 0 AF XY: 0.000380 AC XY: 51AN XY: 134340
GnomAD3 exomes
AF:
AC:
109
AN:
247240
Hom.:
AF XY:
AC XY:
51
AN XY:
134340
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000594 AC: 860AN: 1448062Hom.: 0 Cov.: 32 AF XY: 0.000576 AC XY: 415AN XY: 721066
GnomAD4 exome
AF:
AC:
860
AN:
1448062
Hom.:
Cov.:
32
AF XY:
AC XY:
415
AN XY:
721066
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000269 AC: 41AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74362
GnomAD4 genome
AF:
AC:
41
AN:
152144
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:19Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 15 Pathogenic:7Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 21, 2022 | - - |
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant interpreted as Pathogenic and reported on 01-14-2020 by Lab PreventionGenetics. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 04, 2018 | Based on the potential impact of frameshift variants and the evidence, the p.Trp77LeufsTer13 variant is classified as likely pathogenic for Desbuquois dysplasia. - |
Pathogenic, no assertion criteria provided | curation | GeneReviews | Sep 15, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Apr 01, 2021 | CCDC40 c.248delC has been identified in the homozygous or compound heterozygous state in many individuals with primary ciliary dyskinesia 15. This CCDC40 variant (rs397515393) is rare (<0.1%) in a large population dataset (gnomAD: 119/278616 total alleles; 0.04%; no homozygotes) and has been reported in ClinVar (Variation ID: 31069). This frameshift variant is predicted to result in a premature stop codon in exon 3 of 20 likely leading to nonsense-mediated decay and lack of protein production. We consider this variant to be pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | May 11, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 28, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2013 | - - |
not provided Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 14, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29363216, 23891469, 22499950, 21131974, 23255504, 31772028, 31879361, 31980526, 25619595, 22693285) - |
Pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Mar 22, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Mar 01, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Primary ciliary dyskinesia Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change creates a premature translational stop signal (p.Ala83Valfs*84) in the CCDC40 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCDC40 are known to be pathogenic (PMID: 21131974, 22693285, 23255504). This variant is present in population databases (rs397515393, gnomAD 0.08%). This premature translational stop signal has been observed in individuals with primary ciliary dyskinesia (PMID: 21131974, 22693285, 23255504, 25619595). ClinVar contains an entry for this variant (Variation ID: 31069). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Jan 15, 2019 | - - |
Likely pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Aug 01, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2023 | The c.248delC pathogenic mutation, located in coding exon 3 of the CCDC40 gene, results from a deletion of one nucleotide at nucleotide position 248, causing a translational frameshift with a predicted alternate stop codon (p.A83Vfs*84). This mutation has been identified in multiple homozygous and compound heterozygous individuals with primary ciliary dyskinesia (Becker-Heck A et al. Nat. Genet., 2011 Jan;43:79-84; Antony D et al. Hum. Mutat., 2013 Mar;34:462-72). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 22, 2024 | The p.Ala83ValfsX84 variant in CCDC40 has been previously reported in 19 homozygous and 7 compound heterozygous individuals with primary ciliary dyskinesia (PCD) and segregated with disease in 1 homozygous affected relative (Becker-Heck 2011 PMID: 21131974, Nakhleh 2012 PMID: 22499950, Antony 2013 PMID: 23255504, Zariwala 2013 PMID: 23891469). This variant has been identified in 0.074% (860/1167354) of non-Finnish European chromosomes by gnomAD (http://gnomad.broadinstitute.org). However, this frequency is low enough to be consistent with a recessive allele frequency. This variant has also been reported in ClinVar (Variation ID 31069). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 83 and leads to a premature termination codon 84 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Functional studies indicate that loss of CCDC40 function results in abnormal cilia structure and motility (Becker-Heck 2011 PMID: 21131974). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive primary ciliary dyskinesia. ACMG/AMP Criteria applied: PVS1, PM3_VeryStrong, PM2_Supporting, PP1. - |
CCDC40-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 13, 2024 | The CCDC40 c.248delC variant is predicted to result in a frameshift and premature protein termination (p.Ala83Valfs*84). This variant has been reported in the compound heterozygous and homozygous states in many unrelated individuals with primary ciliary dyskinesia (Becker-Heck et al. 2011. PubMed ID: 21131974; Zariwala et al. 2013. PubMed ID: 23891469, Table S1, Blanchon et al. 2019. PubMed ID: 31772028; Fassad et al. 2019. PubMed ID: 31879361; Hou et al. 2020. PubMed ID: 31980526). This variant is reported in 0.078% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at